Moody Aldrich Partners LLC Ultragenyx Pharmaceutical Inc. Transaction History

Moody Aldrich Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$92.19 - $115.71 $2.41 Million - $3.03 Million	-26,180 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$106.9 - $167.73 $47,891 - $75,143	448 Added 1.74%	26,180 $2.98 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $5,064 - $10,643	60 Added 0.23%	25,732 $3.56 Million
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $1.87 Million - $2.31 Million	25,672 New	25,672 $2.11 Million

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.